首页|TACE联合射频消融术后肝癌残留或复发的影像学研究进展

TACE联合射频消融术后肝癌残留或复发的影像学研究进展

扫码查看
肝动脉化疗栓塞术(transcatheter arterial chemoembolization,TACE)联合射频消融术(radiofrequency ablation,RFA)是中晚期肝癌的有效治疗手段,但病灶术后残留或复发是影响联合治疗疗效的重要因素.影像学检查在肝癌患者随访中扮演重要角色,其中包括数字减影血管造影(DSA)、肝脏超声检查、CT、磁共振(MRI)以及正电子发射断层扫描(positron emission tomography,PET)等,本文将对TACE联合RFA术后残留或复发的影像学技术应用情况作一综述.
Progress of Imaging Assessment in Residual or Recurrent Lesions after Transcatheter Arterial Chemoembolization Combined with Radiofrequency Ablation
Transcatheter arterial chemoembolization(TACE)combined with radiofrequency ablation(RFA)is an effective treatment for advanced liver cancer,but postoperative residual or recurrence of lesions is an important factor affecting the efficacy of combined therapy.lmaging examinations play an important role in the follow-up of liver cancer patients,including digital silhouette angiography(DSA),liver ultrasonography,CT,magnetic resonance imaging(MRI),and positron emission tomography(PET),etc.Combined with the application of imaging techniques in residual or recurrent lesions after RFA,this review was made.

Hepatocellular CarcinomaChemoembolizationRadiofrequency AblationActive LesionImaging

朱楠、张甜甜、周春泽

展开 >

安徽省蚌埠市中医医院影像科(安徽蚌埠 233000)

安徽省五河县人民医院药剂科(安徽蚌埠 233300)

中国科学技术大学附属第一医院介入放射科(安徽合肥 231000)

肝癌 化疗栓塞 射频消融 残留或复发 影像学

安徽省重点研究与开发计划项目安徽省科研编制计划项目安徽省自然科学基金项目

202004j070200132022AH0401922108085MH302

2024

中国CT和MRI杂志
北京大学深圳临床医学院 北京大学第一医院

中国CT和MRI杂志

CSTPCD
影响因子:1.578
ISSN:1672-5131
年,卷(期):2024.22(1)
  • 13